Globe Life (NYSE:GL) EVP Michael Clay Majors Sells 30,000 Shares of Stock

Globe Life Inc. (NYSE:GL) EVP Michael Clay Majors sold 30,000 shares of the company’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $146.89, for a total value of $4,406,700.00. Following the completion of the sale, the executive vice president owned 47,066 shares of the company’s stock, valued at $6,913,524.74. This represents a 38.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Globe Life Price Performance

Shares of GL opened at $141.44 on Tuesday. The stock has a market cap of $11.26 billion, a P/E ratio of 10.05 and a beta of 0.47. Globe Life Inc. has a 1 year low of $109.38 and a 1 year high of $152.71. The stock’s 50-day moving average price is $139.55 and its two-hundred day moving average price is $138.24. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The firm had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business’s revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current year.

Analyst Upgrades and Downgrades

GL has been the subject of a number of research analyst reports. Piper Sandler reissued an “overweight” rating and issued a $167.00 target price on shares of Globe Life in a research note on Friday, November 21st. Weiss Ratings cut Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, January 14th. Morgan Stanley reaffirmed an “overweight” rating and issued a $176.00 price target on shares of Globe Life in a research note on Monday, December 15th. Wells Fargo & Company lowered their price objective on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research report on Friday, October 24th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $171.00.

Hedge Funds Weigh In On Globe Life

A number of large investors have recently modified their holdings of GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Globe Life by 6.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after acquiring an additional 607 shares during the last quarter. NewEdge Advisors LLC grew its stake in Globe Life by 368.1% in the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after purchasing an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Globe Life by 11.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock worth $74,161,000 after purchasing an additional 58,163 shares during the last quarter. Empowered Funds LLC acquired a new position in shares of Globe Life during the 1st quarter worth approximately $428,000. Finally, Focus Partners Wealth raised its stake in shares of Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock worth $1,127,000 after purchasing an additional 656 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.